DISEASE CATEGORY: Infectious disease
INDICATION: Coronavirus; influenza CRISPR-Cas13a knockdown of the nucleocapsid protein of SARS-CoV-2 or influenza’s viral RNA polymerase could

BioCentury | May 2, 2020

Translation in Brief

ORIC’s CD73 inhibitor for cancer; plus Beam, CRISPR-Cas13 for respiratory infections, COVID-19 complex structure, and more

BioCentury’s roundup of preclinical news

BioCentury | Feb 19, 2020

Product Development

COVID-19 update: Sanofi enters vaccine race with BARDA collaboration; plus J&J-BARDA expansion, clinical and diagnostic advances, and more

BioCentury | Oct 10, 2019

Tools & Techniques

Broad takes RNA CRISPR into viral infections

Cas13 continues to prove its worth as the latest Broad CRISPR study points to antiviral applications

BioCentury | Oct 7, 2019

Emerging Company Profile

Gene editing vets launch Korro to convert RNA bases

Atlas, NEA launch Korro with new take on RNA base editing, trio of gene editing veterans

BioCentury | Jun 14, 2019

Emerging Company Profile

Sherlock: Leveraging CRISPR, synthetic biology for diagnostics

How Sherlock is leveraging CRISPR gene editing, synthetic biology to rapidly and accurately detect disease

BioCentury | Mar 21, 2019

Financial News

Sherlock debuts to develop CRISPR diagnostics with IP from Broad, Harvard

Items per page:

1 - 10 of 17